Medexus Pharmaceuticals (MEDXF) Short Interest Ratio & Short Volume → America’s worst nightmare? (From Porter & Company) (Ad) Free MEDXF Stock Alerts $1.21 +0.02 (+1.68%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Medexus Pharmaceuticals Short Interest DataCurrent Short Volume119,300 sharesPrevious Short Volume103,600 sharesChange Vs. Previous Month+15.15%Dollar Volume Sold Short$160,458.50Short Interest Ratio / Days to Cover4.1Last Record DateApril 30, 2024Today's Trading Volume8,650 sharesAverage Trading Volume18,024 sharesToday's Volume Vs. Average48% Short Selling Medexus Pharmaceuticals ? Sign up to receive the latest short interest report for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMEDXF Short Interest Over TimeMEDXF Days to Cover Over TimeMEDXF Percentage of Float Shorted Over Time Ad Porter & CompanyAmerica’s worst nightmare?What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. Medexus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024119,300 shares $160,458.50 +15.2%N/A4.1 $1.35 4/15/2024103,600 shares $118,259.40 +30.5%N/A2.4 $1.14 3/31/202479,400 shares $96,788.60 +14.6%N/A3.1 $1.22 3/15/202469,300 shares $81,081.00 +56.8%N/A2.8 $1.17 2/29/202444,200 shares $58,286.54 +122.1%N/A2.1 $1.32 2/15/202419,900 shares $27,462.00 +192.7%N/A0.3 $1.38 Get the Latest News and Ratings for MEDXF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20247,800 shares $15,522.00 +333.3%N/A0.2 $1.99 12/31/20231,800 shares $3,402.00 No ChangeN/A0.1 $1.89 11/30/20234,200 shares $4,552.80 +35.5%N/A0.4 $1.08 11/15/20233,100 shares $4,092.00 -67.4%N/A0.3 $1.32 10/31/20239,500 shares $13,965.00 -84.3%N/A0.9 $1.47 10/15/202360,300 shares $108,540.00 -92.6%N/A6.8 $1.80 9/30/2023814,300 shares $1.82 million -5.6%N/A63.6 $2.24 9/15/2023863,000 shares $2.06 million -6.7%N/A65.9 $2.39 8/31/2023925,000 shares $2.00 million +97.5%N/A24.8 $2.16 8/15/2023468,300 shares $894,453.00 -1.2%N/A8.4 $1.91 7/31/2023474,200 shares $751,607.00 -0.3%N/A46.5 $1.59 7/15/2023475,600 shares $731,472.80 +16.2%N/A23 $1.54 6/30/2023409,300 shares $568,927.00 +0.4%N/A11.2 $1.39 6/15/2023407,600 shares $362,111.84 -0.6%N/A64.7 $0.89 5/31/2023410,000 shares $378,020.00 -0.1%N/A64.1 $0.92 5/15/2023410,200 shares $370,369.58 -1.3%N/A26 $0.90 4/30/2023415,500 shares $400,001.85 +1.8%N/A62 $0.96 4/15/2023408,200 shares $449,020.00 -1.0%N/A14 $1.10 3/31/2023412,200 shares $491,466.06 -0.9%N/A19.8 $1.19 3/15/2023415,800 shares $469,854.00 +2.0%N/A80 $1.13 2/28/2023407,600 shares $538,032.00 0.0%N/A10.1 $1.32 2/15/2023407,700 shares $387,315.00 +0.0%N/A14.2 $0.95 1/31/2023407,600 shares $574,716.00 -0.5%N/A10.3 $1.41 1/15/2023409,800 shares $649,533.00 +4.4%N/A9.9 $1.59 12/30/2022392,600 shares $604,604.00 -1.3%N/A14.5 $1.54 12/15/2022397,700 shares $562,586.42 +0.1%N/A12.5 $1.41 11/30/2022397,500 shares $680,758.50 +11.2%N/A19.1 $1.71 11/15/2022357,500 shares $493,350.00 +0.3%N/A9.3 $1.38 10/31/2022356,300 shares $381,241.00 +2.6%N/A15.6 $1.07 10/15/2022347,300 shares $309,097.00 +37.3%N/A7.1 $0.89 9/30/2022253,000 shares $179,655.30 +41.7%N/A2.3 $0.71 9/15/2022178,500 shares $255,255.00 -4.6%N/A12.4 $1.43 8/31/2022187,100 shares $357,361.00 +298.1%N/A8.5 $1.91 8/15/202247,000 shares $114,680.00 -23.1%N/A1.8 $2.44Look Who Fired the World’s Richest Man (Ad)This company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. MEDXF Short Interest - Frequently Asked Questions What is Medexus Pharmaceuticals' current short interest? Short interest is the volume of Medexus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 119,300 shares of MEDXF short. Learn More on Medexus Pharmaceuticals' current short interest. What is a good short interest ratio for Medexus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MEDXF shares currently have a short interest ratio of 4.0. Learn More on Medexus Pharmaceuticals's short interest ratio. Is Medexus Pharmaceuticals' short interest increasing or decreasing? Medexus Pharmaceuticals saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 119,300 shares, an increase of 15.2% from the previous total of 103,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Medexus Pharmaceuticals stock? Short selling MEDXF is an investing strategy that aims to generate trading profit from Medexus Pharmaceuticals as its price is falling. MEDXF shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medexus Pharmaceuticals? A short squeeze for Medexus Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDXF, which in turn drives the price of the stock up even further. How often is Medexus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDXF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: TGIFF Short Squeeze CATV Short Squeeze FFNTF Short Squeeze ABSCF Short Squeeze ACRDF Short Squeeze ACRHF Short Squeeze ALEAF Short Squeeze LBTSF Short Squeeze ALVOW Short Squeeze ERBB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MEDXF) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals